2 global trials show mixed results for astegolimab for treating COPD
One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech reports.| COPD News Today
A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive pulmonary disease (COPD) has failed to meet its main goal of showing the therapy’s superiority over a placebo in terms of the ability to reduce the rate of moderate or severe COPD exacerbations. Following the trial’s negative results, […] The post Phase 3 trial testing benralizumab in COPD patients misses main goal appeared first on COPD News Today.| COPD News Today – The Web's Daily Resource for COPD Disease News
One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech reports.| COPD News Today
